Program
Disclaimer: This site has been created by www.MedicAnimal.com for information purposes only. MedicAnimal is a proud retailer of Program but is not affiliated with or related to the manufacturer of Program and the contents of this site are neither sponsored or endorsed by the manufacturer of Program.
Buy Program
Introduction
1. Program for Dogs
2. Program Plus for Dogs
3. Program Suspension for Cats
Presentation
1. Program for Dogs
Presentation Round, biconvex tablets with four different colours and imprinted codes.
Yellow tablets contain: | 23.1 mg lufenuron CGV (side 1) IC (side 2) |
Red tablets contain: | 67.8 mg lufenuron CGV (side 1) FMF (side 2) |
Grey tablets contain: | 204.9 mg lufenuron CGV (side 1) GBG (side 2) |
White tablets contain: | 409.8 mg lufenuron CGV (side 1) DDD (side 2) |
2. Program Plus for Dogs
Active ingredients: milbemycin oxime and lufenuron.
Coated tablets are available in 4 different sizes:
Red outer pack, tablets contain: 2.3mg milbemycin oxime and 46mg lufenuron
Green outer pack, tablets contain: 5.75mg milbemycin oxime and 115mg lufenuron
Yellow outer pack, tablets contain: 11.5mg milbemycin oxime and 230mg lufenuron
White outer pack, tablets contain: 23mg milbemycin oxime and 460mg lufenuron
3. Program Suspension for Cats
White aqueous suspension for oral administration.
For small cats and kittens
Package contains six ampoules wrapped in foil laminate sachet. One ampoule dispenses 1.9 g of suspension containing 133 mg of the active ingredient lufenuron.
For large cats
Package contains six ampoules wrapped in foil laminate sachet. One ampoule dispenses 3.8 g of suspension containing 266 mg of the active ingredient lufenuron.
Uses
1. Program for Dogs
For the prevention and lasting control of flea infestation and the treatment of flea allergic dermatitis in dogs. Program is effective against the dominant flea species Ctenocephalides felis and C. canis. Program tablets can be administered to all dogs including pregnant bitches and puppies taking solid food.
2. Program Plus for Dogs
PROGRAM PLUS tablets are indicated for the prevention of fleas (Ct. felis, Ct. canis, preadult stages), and for the concurrent prevention of heartworm disease (elimination of 3rd and 4th larval stages of Dirofilaria immitis) and/or treatment of adult stages of gastrointestinal nematodes such as hookworms (Ancylostoma caninum), roundworms (Toxocara canis) and whipworms (Trichuris vulpis) in dogs.
3. Program Suspension for Cats
For the prevention and lasting control of flea infestation and the treatment of flea allergic dermatitis in cats. Program is effective against the dominant flea species Ctenocephalides felis and C. canis. Program suspension can be administered to all cats including pregnant cats and kittens taking solid food.
Dosage & administration
1. Program for Dogs
Dosage schedule for PROGRAM Tablets for Dogs | ||||
Dog weight | Yellow tablets (23.1 mg ai) | Red tablets (67.8 mg ai) | Grey tablets (204.9 mg ai) | White tablets (409.8 mg ai) |
Up to 2.3 kg | 1 tablet | |||
2.3 kg to 6.7 kg | 1 tablet | |||
6.8 kg to 20 kg | 1 tablet | |||
21 kg to 40 kg | 1 tablet | |||
41 kg to 80 kg | 2 tablets | |||
Dosage
The minimum recommended dose rate is 10 mg/kg/month. When dosing puppies and growing dogs, the dose dispensed should be based on the animals expected weight at the end of the six month treatment period.
Recommended monthly dose
See table "Dosage schedule for PROGRAM Tablets for Dogs".
Administration
To be fully effective the tablets must be administered together with food, eg, added into a portion of the daily food, hidden in pieces of meat, etc or administered by mouth after feeding. After administration, the dog should be watched for several minutes to ensure that the whole dose has been swallowed.
To prevent flea infestations Program should be administered at monthly intervals for at least six months during the flea season, starting two months before fleas become active.
If the dog is already infested with fleas, no viable flea eggs are produced from 24 hours after the first administration. The speed of elimination of a pre-existing infestation is dependent upon the number of flea larvae and pupae in the environment when treatment starts and the climatic conditions.
If dogs have a high level of flea infestation at the start of the treatment, it may be necessary to administer a flea adulticide during the first one to two months. In cases of severe hypersensitivity further use of an adulticide may be needed.
It is essential that all dogs and all cats (except unweaned puppies and kittens) living in a household are treated with Program to stop flea reproduction.
For cats, use Program suspension or Program injectable
2. Program Plus for Dogs
PROGRAM PLUS tablets are administered at a minimum dose of 0.5 mg milbemycin oxime and 10 mg lufenuron per kg body weight.
PROGRAM PLUS tablets are available in four sizes and are given according to the weight of the dog.
Colour code of outer pack | Body weight (kg) | Posology (tablet/month) |
red green yellow white | up to 4.5 kg from 5 to 11 kg from 12 to 22 kg from 23 to 45 kg | 1 tab./month 1 tab./month 1 tab./month 1 tab./month |
For dogs greater than 45 kg, a combination of tablets is given, consistent with the recommended minimum dose.
PROGRAM PLUS tablets should be administered in the following situations:
Puppies
To prevent flea infestations with concurrent heartworm prevention and/or gastrointestinal nematode infection medication should start from 2 weeks of age, or from a minimum weight of 1 kg.
Dogs in a non-heartworm region
PROGRAM PLUS can be used as part of the seasonal prevention of fleas replacing lufenuron mono (PROGRAM tablets) in cases with diagnosed concurrent gastrointestinal nematode infection. After elimination of the nematode infection confirmed by faecal examination, prevention of fleas should continue with PROGRAM tablets if indicated.
In puppies, medication with PROGRAM PLUS is recommended up to one month after weaning. Thereafter, prevention of fleas can be continued with lufenuron mono (PROGRAM).
Dogs travelling to a heartworm region
To prevent flea infestations and heartworm disease at the same time, dogs travelling to a heartworm risk region should begin medication within one month after arrival. Treatment should continue monthly, with the last administration given after the dog has left the region.
Dogs in a heartworm region
Dogs in a heartworm region:To prevent flea infestations and heartworm disease at the same time, medication should begin within one month after the appearance of mosquitoes, or one month before the appearance of fleas, and continue throughout the risk period with the last dose given within one month after the mosquito and flea season finishes.
If dogs have a high level of flea infestation at the start of treatment, it may be necessary to apply a flea adulticide during the first one to two months. It is important to treat all dogs and cats in the household for fleas. Cats in the same household should be treated with PROGRAM oral or injectable suspension.
Advice on Correct Administration
To ensure adequate drug absorption, PROGRAM PLUS tablets must be administered with food (for example mixed with the daily feed) or placed directly in the mouth after feeding.
Treatment with PROGRAM PLUS tablets may begin at any time of the year. In geographic areas where the presence of fleas and mosquitoes (heartworm vector) is seasonal, depending on ambient temperature, treatment should be started one month prior to the appearance of the insects and then repeated monthly throughout the risk period. In environments with year-round flea infestations and concurrent heartworm risk, treatment may be continued throughout the year without interruption.
Ideally, tablets are administered on the same day each month. If an interval is greater than 6 weeks, treatment should be resumed immediately and be continued at monthly intervals and, in case of heartworm prevention, a veterinarian should be consulted.
PROGRAM PLUS tablets immediately block the reproductive cycle of fleas by inhibiting the development of eggs and larvae. Pre-existing generations (e.g. pupae) present in the environment can, however, continue to develop and emerge for several weeks after the start of treatment.
3. Program Suspension for Cats
Dosage
The minimum recommended dose rate is 30 mg/kg/month. This is achieved by giving:
Cats and kittens up to 4.5 kg—content of 1 ampoule containing 1.9 g of suspension/month
Cats over 4.5 kg—content of 1 ampoule containing 3.8 g of suspension/month.
Administration
To be fully effective the suspension must be administered together with food.
Shake the ampoule prior to opening.
The suspension should be added into approximately half of the food ration. The rest of the food should be presented when all the dose has been eaten. If several cats are treated, ensure that each cat is fed individually. The product can also be administered by squeezing the suspension directly from the ampoule onto the back of the cat's tongue after feeding.
To open the ampoule first hold the base tab (which has writing on it) and flick the pack. Then twist off the top portion and squeeze the ampoule several times to administer the suspension.
To prevent flea infestations Program should be administered at monthly intervals for at least six months during the flea season, starting two months before fleas become active.
If the cat is already infested with fleas, no viable flea eggs are produced from 24 hours after the first administration. The speed of elimination of the infestation is dependent upon the number of flea larvae and pupae in the environment when treatment starts and climatic conditions.
If cats have a high level of flea infestation at the start of the treatment, it may be necessary to administer a flea adulticide during the first one to two months. In cases of severe hypersensitivity, further use of an adulticide may be needed.
It is essential that all cats and dogs (except unweaned puppies and kittens) living in a household are treated with Program to stop flea reproduction.
For dogs, use Program tablets.
Price comparison
Contra-indications, warnings, etc.
1. Program for Dogs
Contra-indications
None. The product is compatible with other flea control products.
Warnings
Wash hands after use. Any unused product or waste material should be disposed of in accordance with national requirements.
2. Program Plus for Dogs
In heartworm risk regions, or if it is known that a dog has been travelling to and from heartworm risk regions, before commencing PROGRAM PLUS treatment as with any other heartworm preventive, a veterinary consultation is advised to exclude the presence of any concurrent infestation of Dirofilaria immitis. In the case of a positive diagnosis, adulticidal therapy is indicated before administering PROGRAM PLUS.
Pale mucous membranes and increased intestinal peristalsis have been observed in some dogs after treatment. The treatment of dogs with a high number of circulating microfilariae can sometimes lead to the appearance of moderate and transitory hypersensitivity reactions, such as pale mucous membranes, vomiting, laboured breathing, or excessive salivation. These reactions are associated with the release of proteins from dead or dying microfilariae and are not a direct toxic effect of the product.
If you notice any other side effects, please inform your veterinary surgeon.
Warnings
For animal treatment only.
To be sold on presentation of a veterinary prescription only.
Special Precautions for the Disposal of Unused Veterinary Medicinal Product or Waste Materials Derived from such Veterinary Medicinal Products.
Any unused PROGRAM PLUS tablets or waste materials derived from them should be disposed of in accordance with national requirements.
3. Program Suspension for Cats
Contra-indications
None. The product is compatible with other flea control products.
Warnings
Avoid contact with skin and eyes. If contact occurs, wash the affected area with clean water immediately. Seek medical attention if irritation persists. Wash hands after use. Any unused product or waste material should be disposed of in accordance with national requirements.
Pharmaceutical precautions
1. Program for Dogs
Keep out of the reach of children. For oral treatment only. For animal treatment only. Store in a dry place. Protect from light.
2. Program Plus for Dogs
Keep out of the reach and sight of children.
Do not store above 25°C.
Keep the blister strips in the outer carton.
3. Program Suspension for Cats
Keep out of the reach of children. For animal treatment only. For oral treatment only. Do not store above 25°C.
Packaging quantities
1. Program for Dogs
Blister packs of six tablets.
2. Program Plus for Dogs
Plastic blister packs each containing 6 tablets.
3. Program Suspension for Cats
Pack of six ampoules.
Further information
1. Program for Dogs
Program contains lufenuron, a benzoylurea derivative.
After administering Program orally to the dog, the active ingredient is quickly absorbed. Sufficient absorption is only achieved if administered on a full stomach. The low excretion rate assures an effective concentration of the active ingredient in the blood for one month.
Fleas take up the active ingredient through the blood and transfer it to their eggs. The formation of larval chitin structures, a process typical to insects, is blocked and the development of their numerous offspring is stopped. A new infestation of the home with fleas is prevented.
Fleas picked up by the dog outside the home environment are prevented from causing a new infestation of the home.
2. Program Plus for Dogs
Milbemycin oxime, which belongs to the group of macrocyclic lactones, is active against mites, against larval and adult stages of nematodes as well as against larvae of Dirofilaria immitis.
No alteration of reproductive function, neither foetal nor neonatal toxicity has been reported for lufenuron and milbemycin oxime used as a monotherapy in dogs.
3. Program Suspension for Cats
Program contains lufenuron, a benzoylurea derivative.
After administering Program orally to the cat, the active ingredient is quickly absorbed. Sufficient absorption is only achieved if administered on a full stomach. The low excretion rate assures an effective concentration of the active ingredient in the blood for one month.
Fleas take up the active ingredient through the blood and transfer it to their eggs. The formation of larval chitin structures, a process typical to insects, is blocked and the development of their numerous offspring is stopped. A new infestation of the home with fleas is prevented.
Fleas picked up by the cat outside the home environment are prevented from causing a new infestation of the home.
Disclaimer
This site has been created by www.MedicAnimal.com for information purposes only. MedicAnimal is a proud retailer of Program but is not affiliated with or related to the manufacturer of Program and the contents of this site are neither sponsored or endorsed by the manufacturer of Program.